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Newcastle disease is an economically important disease of poultry for which vaccination is applied as a
preventive measure in many countries. Nevertheless, outbreaks have been reported in vaccinated
populations. This suggests that either the vaccination coverage level is too low or that vaccination does
not provide perfect immunity, allowing the virus to spread in partially vaccinated populations. Here we study
the requirements of an epidemiologically effective vaccination program against Newcastle disease in poultry,
based on data from experimental transmission studies. The transmission studies indicate that vaccinated
birds with low or undetectable antibody titres may be protected against disease and mortality but that
infection and transmission may still occur. In fact, our quantitative analyses show that Newcastle disease
virus is highly transmissible in poultry with low antibody titres. As a consequence, herd immunity can only
be achieved if a high proportion of birds ( 85%) have a high antibody titre (log2 haemagglutination
inhibition titre ]3) after vaccination. We discuss the implications for the control of Newcastle disease in
poultry by vaccination.
Introduction
Newcastle disease (ND) is a highly contagious viral
disease affecting wild and domestic avian species (Seal
et al., 2000; Alexander, 2003). The impact of ND is most
notable in domestic poultry due to the high susceptibility
of poultry and the severe consequences of outbreaks of
virulent strains on the poultry industries. In fact, it has
been argued that ND may represent a bigger drain on
the world economy than any other animal viral disease
(Alexander, 2003), although the current epizootics of
H5N1 avian influenza in Southeast Asia are challenging
(if not surpassing) this status.
In response to the threat presented by ND, several
countries have put in place vaccination campaigns to
prevent epizootics. However, outbreaks have been re-
ported in vaccinated populations despite the fact that
vaccination is widely applied (Burridge et al., 1975), as
for example in The Netherlands in 1992 to 1993, the UK
in 1997, and the USA in 2002 (Alexander, 2003, and
references therein).
It is known that vaccination of poultry provides an
excellent means to lessen clinical signs of infection
caused by virulent Newcastle disease virus (NDV)
(Alexander, 2003; Senne et al., 2004; Kapczynski &
King, 2005). It has also been known for a long time that
vaccination itself (with live vaccines based on non-
virulent virus strains) may cause disease and reduced
growth in vaccinated birds (Alexander, 2003). As a
consequence, there has been a trend to use ever less
virulent strains as the seed viruses for vaccine produc-
tion. Although this strategy has reduced the disease rates
after vaccination, it also may have contributed to the fact
that current vaccines and vaccination campaigns are not
maximally effective in preventing infection and transmis-
sion (Burridge et al., 1975; Voeten et al., 1987; Alex-
ander, 2003; Senne et al., 2004; Kapczynski & King,
2005). Hence, it is not clear whether the ultimate goal of
prevention of major outbreaks after primary virus
introductions can be achieved with current vaccines
and vaccination programmes.
Vaccination of large numbers of broiler chickens
against ND is usually carried out using non-virulent
live virus that is administered by spray or atomist, or via
drinking water. These administration techniques usually
produce considerable variation in the individual anti-
body immune responses of vaccinated birds, indicating
potential variation in the levels of protection after
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question in the control of ND is whether virulent viruses
are able to spread in heterogeneously vaccinated popula-
tions, and, more specifically, under which conditions
(vaccination coverage level, distribution of antibody
titres) epidemic spread can be prevented.
To determine whether poultry flocks are at risk of
major outbreaks of ND we use the concept of ‘herd
immunity’ (Anderson & May, 1991; Diekmann &
Heesterbeek, 2000). Epidemiological theory informs us
that whether a population is protected against epidemic
spread of an infectious agent or not is determined by the
reproduction numbers of the infectious agent in popula-
tions with high and low levels of protection after
vaccination, and by the fraction of animals that have a
high level of protection after vaccination. ‘Herd immu-
nity’ is achieved if the fraction of animals with a high
level of protection is equal to or greater than a certain
critical fraction of animals with a high level of protec-
tion. The critical vaccination fraction is in turn deter-
mined by the reproduction numbers of the infectious
agent in populations with high and low levels of
protection (see Materials and Methods for details). The
central aim of the present study is therefore to provide
estimates of the reproduction numbers of NDV in bird
populations with high and low levels of protection after
vaccination.
To this end we have carried out an extensive set of
experiments with various virus vaccine combinations.
All experiments were performed with broilers that
received two vaccine doses, thereby mimicking vaccina-
tion schemes in the field. The experiments were carried
out with birds that had a low antibody titre (as
determined by the haemagglutination inhibition test)
after vaccination (log2 titre: 0 2), andwith birds that had
a high antibody titre after vaccination (log2 titre
]3). Throughout we have utilized two commonly used
vaccines that are based on the mildly virulent (lento-
genic) La Sota and Ulster strains (Alexander, 2003). As
challenge virus we used three well-known highly virulent
(velogenic) strains: Herts33/56, Netherlands/93, and
California/71. On the basis of the data of these experi-
ments we estimated the reproduction numbers of NDV
in groups of broilers with low and high antibody titres.
We discuss the implications of our findings for the design
of vaccines and vaccination campaigns aimed at protec-
tion of poultry flocks against major outbreaks of ND.
Materials and Methods
Epidemiological considerations. Whether or not a major outbreak can
occur after a primary introduction of an infectious agent into a
population is determined by the (basic) reproduction number, which
gives the expected number of secondary infections caused by one
infected individual in a large population in the early stages of an
outbreak. If the reproduction number (R) exceeds the threshold value of
1 a chain reaction of infection events is possible, and an epidemic can
occur. If, on the other hand, the reproduction number remains below
the threshold value of one, a major outbreak cannot occur. In a
standard compartmental SEIR model (where the compartments
represent susceptible, exposed but not yet infectious, infected and
infectious, and removed individuals) with one type of infected
individual and permanent immunity after infection or vaccination, R
determines the critical vaccination coverage needed to achieve herd
immunity. In fact, epidemiological theory states that herd immunity is
obtained if the actual vaccination coverage exceeds the critical
vaccination coverage pc, which is given by pc 1 1/R (Anderson &
May, 1991).
ND vaccines, however, do not provide unconditional immunity
against infection and transmission, and the individual responses to
vaccination can be highly variable. As a consequence, we have to adapt
the above considerations to allow for variable immunity after vaccina-
tion. To keep the analyses manageable, we consider a model with two
immune classes: one with a low level of protection against infection and
disease, and one with a high level of protection against infection and
disease. With two types of individuals, the overall reproduction number
depends on the reproduction numbers of the virus in homogeneous
populations with high and low levels of protection (Rhigh and Rlow)a s
follows:
R pRhigh (1 pRlow);
where p is the fraction of individuals that has a high level of protection
(Diekmann & Heesterbeek, 2000).
The critical fraction of individuals that needs to have a high level of
protection in order for the population to achieve herd immunity, pc,i s
given by setting p pc and solving the above equation for R 1. A
straightforward calculation shows that:
pc 
Rlow   1
Rlow   Rhigh
: (1)
The above theoretical considerations can be refined and extended in a
number of directions, but for the present purposes Equation (1) suffices
as a rule of thumb specifying the requirements of an epidemiologically
effective vaccination programme.
Equation (1) implies that herd immunity cannot be achieved
whenever the infectious agent is able to spread epidemically in
populations with a high level of protection (i.e. if Rhigh 1), and that
no animals need to have a high level of protection whenever the
pathogen cannot spread epidemically in populations with a low level of
protection (i.e. if RlowB1). In the special case that a high level of
protection guarantees that no transmission can occur (Rhigh 0)
Equation (1) reduces to the familiar pc 1 1/Rlow.
Experimental approach. To determine the transmission dynamics of
NDV in vaccinated and unvaccinated poultry living in close contact
groups, a number of experimental transmission studies with broiler
chickens were carried out. All experiments were performed in a high-
containment unit under BSL3  conditions at the Central Institute for
Animal Disease Control Lelystad. The experiments complied with the
Dutch law on animal experiments and were reviewed by an ethical
committee. The design of transmission experiments has been described
before (de Jong & Kimman, 1994; Bouma et al., 1996; van der Goot
et al., 2005). Briefly, a number of birds that were inoculated with the
virus at the start of the experiment were housed with a number of
uninfected contact birds. During the course of the experiments the
status of the birds (normal, sick, and dead) was recorded, and the
serological status of each birdwas determined at the start and at the end
of the experiments.
Birds were vaccinated at 1 day old by spraying with commercial
vaccines*either La Sota (Nobilis† ND clone 30) in Experiments 1 to 3
and Experiments 5 to 7, or Ulster (Poulvac NDW) in Experiments 4
and 8*and received a booster vaccination with the same vaccine using
an atomist between 8 and 20 days of age. Birds were transported to
animal BSL-3  facilities of the CIDC-Lelystad laboratory between 22
and 26 days of age, well before the start of the actual challenge
experiments. In each experiment 10 birds were inoculated with virus and
housed together at day 0. Subsequently, 10 uninfected contact birds
were added to the inoculated birds at day 1.
Three different viruses were used for challenge infection (Table 1).
For Experiments 1, 4, 5, and 8, a velogenic NDV Netherlands/93
(APMV-1/Netherlands/152608/93) was used. This virus was isolated in
The Netherlands during the 1992 to 1993 epizootic from a vaccinated
layer flock, and was characterized as a velogenic virus based on the
amino acid residues (RRQKR.F) at the cleavage site of the fusion
protein. The virus has an intracerebral pathogenicity index (ICPI) of
1.84. Phylogenetic analysis has placed the virus in clade 5a (Aldous
et al., 2003) or genotype VII (Lomniczi et al., 1998). In Experiments 2
2M . van Boven et al.and 6, Herts33/56 was used as the challenge virus. The Herts33/56 virus
used in this study had an ICPI of 1.86, and was obtained from the
Veterinary Laboratory Agency (UK) in 1973. Herts33/56 is placed
within lineage group 3b (Aldous et al., 2003) or genotype IV (or the
separate genotype W) (Lomniczi et al., 1998; Czegledi et al., 2006). In
Experiments 3 and 7, a viscerotropic velogenic California/71 virus
(Calfornia 2098/71) was used. This virus was isolated form a chicken
during the ND outbreak in California in 1971 and was received from Dr
Hanson of the University of Wisconsin. This virus has an ICPI of 1.8
and is placed in clade 3c or genotype V. Animals were challenged via the
trachea (0.1 ml) and the nasal cavity (0.1 ml) with a suspension
containing 10
6 median egg infectious doses (EID50) for Experiments 1
and 5, 10
6 EID50 for Experiments 2 and 6, 10
6.4 EID50 for Experiments
3 and 7, and 10
3.8 EID50 for Experiments 4 and 8.
The haemagglutination inhibition (HI) test was performed according
to standard EU protocol (EU Council Directive 92/66/EEC). For the
test, the amount of Ulster/66 ND antigen was adjusted to 8
haemagglutinating units. Controls on the antigen content in the HI
test were carried out using serial two-fold dilutions starting at 1:2, 1:3,
1:4, 1:5, and 1:6. The test was considered valid when the amount of
antigen in the control lies between 6 and 9 haemagglutinating units (1
unit being the dilution at which 100% agglutination is still observed).
The titre was determined testing two-fold dilution series of sera, and the
titre was expressed as the highest dilution showing complete inhibition
of agglutination. In each HI test run, a negative control and sera with
low, mean and high titre were included. Test results are considered valid
only when the titre of these reference sera did not deviate more than one
dilution step up or down from the mean.
Throughout we classified birds with log2 antibody titres in the range 0
to 2 as having a low level of protection, and birds with log2 antibody
titres ]3 as having a high level of protection. This classification scheme
was chosen on the basis of earlier evidence, which suggested that log2
antibody titres ]3 were sufficient to protect against disease (data not
shown), that log2 antibody titres ]3 are very unlikely to result from
non-specific reactions. Moreover, Dutch legislature asks that at least
90% of vaccinated birds of 4 weeks and older have a log2 antibody titre
of at least 3.
Birds that diedwith signs of infection or showed an increase of the HI
titre of at least two log steps were considered to be infected and
infectious after challenge.
Statistical analyses. The analyses of the transmission experiments
follow the line of analyses of earlier transmission experiments with
pseudorabies virus in pigs and highly pathogenic avian influenzavirus in
poultry (de Jong & Kimman, 1994; Bouma et al., 1996; van der Goot
et al., 2005). Throughout, the analyses are based on the final size of the
transmission experiments; that is, on the number of initially uninfected
animals that have been infected during the course of the experiment
(Table 1). Here we assume an exponentially distributed infectious
period, which gives high estimates of the reproduction number and
broad confidence intervals in comparison with models that assume less
variation in the infectious period (Ball, 1986). As a consequence, the
method also yields a fairly high estimate of the critical fraction of
animals that needs to have a high level of protection to obtain herd
immunity.
Confidence intervals of the estimated parameters are calculated as
reported by Velthuis et al. (2007). In short, exact confidence bounds of
the parameter estimates are determined by calculating all possible
values r of the reproduction number R for which the hypothesis H0: R 
r is not rejected; that is, for which the P value is larger than 0.05. In the
case where all contact animals are infected (Experiments 3 and 4) no
estimate of the reproduction number is calculated ( ˆ R 0  ); and only
the lower bound of the (one-sided) 95% confidence interval is given.
Results
NDV infection and disease. All three challenge viruses
used in this study are highly virulent as measured by the
ICPI ( 0.7), and are able to kill experimentally infected,
susceptible chickens within 2 days. In our transmission
experiments with vaccinated birds, however, only a
minority of the birds died during the experiments. In
fact, in the experiments with birds that had high anti-
body titres after vaccination (log2 titre ]3; Experiments
5 to 8), 27 of the 80 contact birds showed signs of
infection (Table 1), and just one of these 27 infected
contact birds died. In the experiments with birds that
had low antibody titres (log2 titre: 0 2; Experiments 1 to
4), the majority of the contact birds had signs of
infection (54 out of 60), but still only a minority of
these infected contact birds died (10 out of 54). Overall,
these results indicate that vaccination provides excellent
protection against mortality after a natural infection
with virulent NDV when vaccinated birds have high
antibody titres, and that vaccination is still quite
effective in reducing mortality rates in birds with low
antibody titres. On the other hand, vaccination does not
seem to provide substantial protection against infection,
especially in birds having low antibody titres.
NDV transmission. The data in Table 1 indicates that for
most virus vaccine combinations the virus is able to
spread extensively in birds with low antibody titres (log2
titre: 0 2). In fact, in Experiment 3 (one trial) and
Experiment 4 (two trials) all contact birds became
infected, and in Experiment 1 (two trials) only one of
the 20 contact birds escaped infection. The results of
Experiment 2 were somewhat different as five out of 10
contact birds escaped infection.
Table 1. Overview of the experimental transmission studies
Number of contact birds
b
Experiment Vaccine Virus HI titre
a (log2) Infected Dead
1 La Sota NL93 0 to 2 9, 10 0, 1
2 La Sota Herts33/56 0 to 2 5 0
3 La Sota California71 0 to 2 10 1
4 Ulster NL93 0 to 2 10, 10 4, 4
5 La Sota NL93 ]3 0 ,4 ,1 0 0 ,0 ,0
6 La Sota Herts33/56 ]3 0, 2 0, 0
7 La Sota California71 ]3 1, 3 0, 1
8 Ulster NL93 ]37 0
Experiments 2, 3, and 8 consist of one trial, Experiments 1, 4, 6, and 7 contain two trials, and Experiment 5 contains three trials. Each
trial initially contained 10 infected birds and 10 uninfected contact birds. The vaccines are based on the La Sota (Nobilis Clone30) and
Ulster (NDW Poulvac) viruses. The challenge viruses are NL93 (APMV-1/chicken/Netherlands/152608/93), Herts33/56, and
California71.
aRange of HI titres of the birds just before the start of the experiment.
bNumber of contact birds that were infected
or died per trial.
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Table 2. The quantitative analyses of Experiments 1 to 4
yield estimates of the reproduction number Rlow varying
from ˆ Rlow 0:95 (95% confidence interval: 0.27 2.8) at
the low end in Experiment 2 to ˆ Rlow 2:1 with 95%
confidence at the high end in Experiment 4. If all
transmission experiments with birds that had a low
antibody titre at the start of the experiment are
combined, we find ˆ Rlow 3:1 (95% confidence interval:
1.8 4.3), and we conclude that, in general, NDV is able
to spread epidemically in groups of vaccinated broilers
with low antibody titres. It should be noted that this
conclusion rests on the assumption of no systematic
differences in the transmission characteristics of the
different viruses. Unfortunately, with the current data
this assumption cannot be validated or falsified.
In groups of birds with high antibody titres there was
more variation in the outcome of the experiments (Table
1). This is mirrored by the statistical analyses, which
show considerable variation in the estimates of the
reproduction number Rhigh: At the low end ˆ Rhigh 0:19
(95% confidence interval: 0.023 0.78) in Experiment 6 to
/ ˆ Rhigh 1:5 (95% confidence interval: 0.50 3.9) at the
high end in Experiment 8. Notice that all experiments
indicate that at least some spread is possible in vacci-
nated birds with high antibody titres, and that Experi-
ments 5 and 8 do not exclude the possibility of epidemic
spread in populations with high antibody titres (i.e.
Rhigh 1): If, however, we assume that differences
between different sets of experiments are the result of
chance and combine all experiments with birds having
high antibody titres, the estimate of the reproduction
number is ˆ Rhigh 0:72 (95% confidence interval: 0.41 
1.0), and we conclude that epidemic spread is unlikely in
groups of birds having high antibody titres.
Herd immunity against NDV by vaccination. Herd
immunity to NDV is obtained whenever the virus is
unable to cause a prolonged chain of infections; that is, if
no epidemic can unfold after a primary virus introduc-
tion (Diekmann & Heesterbeek, 2000). In our context,
‘herd immunity’ is achieved if the fraction of birds that
have a high antibody titre after vaccination exceeds the
critical fraction of birds with a high antibody titre
specified by Equation (1). For the combined analysis
of the experiments (Table 2) and assuming that 100% of
the birds are vaccinated, the critical fraction is estimated
at pc 0.88 (i.e. at least 88% of the birds need to have a
high antibody titre after vaccination to prevent a major
epidemic). We would like to stress that there is consider-
able uncertainty surrounding this estimate. For instance,
if we take the lower and upper bounds of the confidence
intervals of ˆ Rlow and ˆ Rhigh; and insert these values in
Equation (1), we obtain pc 0.58 and pc 1 as lower and
upper bounds of the critical fraction of birds with
high level of protection. In other words, pc may be as
low as 58% or as high as 100%. It should be noted,
however, that these bounds are conservative in view of
our estimation method that yields broad confidence
intervals for the reproduction numbers (see Materials
and Methods).
Also shown in Table 2 is substantial variation in the
estimates of reproduction numbers of the individual
experiments. As a consequence, there is also considerable
variation in the estimates of the critical vaccination
fraction if we focus on experiments with identical virus 
vaccine combinations (Experiments 1 5, Experiments
2 6, Experiments 3 7, Experiments 4 8). For Experi-
ments 2 6 the critical vaccination fraction is estimated
to be 0%, indicating that epidemic spread of virus is
unlikely even in vaccinated populations of birds with low
antibody titres ( ˆ RlowB1): For Experiments 3 7 the
lower bound of the estimate of the critical vaccination
fraction is 46%, and for Experiments 1 5 and Experi-
ments 4 8 herd immunity cannot be achieved even if all
birds have a high antibody titre after vaccination since
the virus is expected to able to spread epidemically even
in populations with high antibody titres ( ˆ Rhigh 1):
Discussion
In this paper we have presented quantitative analyses of
NDV transmission in vaccinated chickens. Our results
indicate that although vaccination in general provides
good protection against disease and mortality, it may not
provide sufficient protection against virus transmission
so as to be able to prevent or halt epidemics of ND. This
finding is of considerable interest as it brings into
question the epidemiological effectiveness of current
vaccination campaigns against ND. Overall, our ana-
lyses indicate that a high fraction of birds ( 85%) needs
to have a high antibody titre (log2 titre ]3) after
vaccination to ensure that no epidemic spread is possible
in vaccinated populations.
In viewofour results, a central question is whether it is
possible to obtain consistently high antibody titres using
the current administration techniques (by spraying or via
the drinking water) of ND vaccines based on viruses of
low virulence. Unfortunately, to date there are no
systematic studies that have investigated the distribution
of antibody titres after vaccination of large populations
of poultry. A pilot experiment in The Netherlands
suggests that it may be possible to obtain high antibody
titres in the majority of birds, but only if strict
preconditions on the vaccine content and administration
techniques are met (data not shown). It should also be
noted that in the absence of circulation of virulent virus
in a region there may be an incentive for farmers to use
vaccination schemes and procedures that are not epide-
miologically optimal because of the negative side-effects
of vaccination.
Table 2. Overview of the statistical analyses
Experiments / ˆ Rlow / ˆ Rhigh
1 5 3.4 (1.5 8.4) 1.1 (0.46 1.7)
2 6 0.95 (0.27 2.8) 0.19 (0.023 0.79)
3 7  1.8
a 0.38 (0.044 0.98)
4 8  2.1
a 1.5 (0.50 3.9)
All 3.1 (1.8 4.3) 0.72 (0.41 1.0)
Data are the combined results of Experiments 1 and 5 (vaccine,
La Sota; virus, NL93), Experiments 2 and 6 (vaccine, La Sota;
virus, Herts33/56), Experiments 3 and 7 (vaccine, La Sota;
virus, California71), Experiments 4 and 8 (vaccine, Ulster;
virus, NL93), and all experiments taken together. ˆ Rlow and ˆ Rhigh
represent the maximum likelihood estimates of Rlow and Rhigh;
which are calculated using the infection data of Table 1. The
95% confidence intervals are presented in parentheses.
aOnly
the lower bound of the (one-sided) 95% confidence interval is
given.
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possibility that the virus might spread unnoticed in
partially vaccinated populations where it would be
detected quickly in unvaccinated populations, thereby
increasing the period in which the virus can be trans-
mitted unchecked. Whether this theoretical possibility
might become a real problem is not known at present.
Certainly, our results and those of Kapczynski and King
(2005) have shown that infection, shedding, and trans-
mission of virulent NDV in vaccinated birds may occur
without overt disease signs. Given this possibility we
believe that, if preventive vaccination programmes are to
be implemented, they should go together with a mon-
itoring programme ensuring that sufficient flock immu-
nity levels are achieved. Similar views have recently been
expressed for highly pathogenic avian influenza viruses
in poultry (Capua & Marangon 2006; Capua & Alex-
ander, 2006; Savill et al., 2006).
Our results have shown some variation in the trans-
mission levels using different combinations of vaccine
and virus (especially in groups of birds with a high
antibody titre). On the one hand, in view of the limited
amount of data for each particular virus vaccine com-
bination, it may be that the variation in transmission is a
result of chance. On the other hand, it may also be that
our data have revealed a trend that hints at variable
efficacy of different vaccines against different viruses (see
also Kapczynski & King, 2005). In this respect, it is of
note that better protection appears to be obtained
against challenge viruses that were isolated in the
1930s and 1970s (i.e. Herts33/56 and California71),
and which are genetically more closely related to current
vaccine strains than the more recently isolated and
genetically more distinct Netherlands/93 virus (Lomniczi
et al., 1998). This is in line with recent results (Czegledi
et al., 2006), which indicated that current vaccines
induced better protection against viruses that were
isolated in past epizootics than against viruses that are
currently circulating. With this in mind, it would be
interesting to investigate the antigenic relationship
between past and current circulating viruses, and the
effect of the antigenic match between virus and vaccine
on the level of protection conferred against disease,
shedding, and transmission. From a practical perspec-
tive, since the effectiveness vaccines is ultimately deter-
mined by their ability to curb or halt epizootics of ND,
we believe that vaccine development should be focused
on providing vaccines that protect against infection and
shedding rather than against disease.
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